Dynamic FDG PET/CT Imaging in Hepatocellular Carcinoma
Key facts
- Who runs it
- First Affiliated Hospital of Chongqing Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 24 people enrolled
- Started
- 1 Dec 2025
- Ended
- 11 Aug 2026
- Type of study
- Interventional
- Treatments tested
- Dynamic and static FDG PET/CT
- Record updated
- 18 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Clinically suspected hepatocellular carcinoma
- Ability to undergo the study PET/CT acquisition and provide written informed consent
- A target liver lesion at least 1.5 cm in diameter, as specified in the current manuscript
- Histopathological assessment and follow-up information available as required by the protocol
Who cannot take part
- Another concurrent malignancy
- Recent transarterial chemoembolisation, radiotherapy or systemic therapy
- Active gastrointestinal bleeding
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Static fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) may be negative in hepatocellular carcinoma even when a tumour is present. Dynamic PET/CT records how the tracer enters, accumulates in and leaves tissues over time. This study evaluates whether kinetic parameter maps provide additional information at the sites of liver tumours that are negative on static FDG PET/CT. Imaging measurements are compared between static FDG-positive and FDG-negative lesions and related to histopathology. Associations with tissue expression of glucose-6-phosphatase, glucose transporter 1, glypican-3 and hexokinase II are also explored.
The group in the trial
- Dynamic and static PET imagingOther group
Treatment: Dynamic and static FDG PET/CT
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Diagnostic Value of [18F]FDG Total-Body Dynamic Imaging in Patients With Hepatocellular Carcinoma
- Record updated
- 18 November 2026